Please assess the completion status of the following clinical trial:

Trial Title: Botox Injection for Treatment of Vaginismus

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Non-pregnant healthy females aged 20-40 with Lamont level 1-4 primary vaginismus.~2. Willing to practice a reliable method of contraception for the first 4 months after treatment.~3. Able to understand and comply with the requirements of the study and sign Informed Consent.~Exclusion Criteria:~1. Female subjects who are pregnant (positive urine pregnancy test), trying to become pregnant, breast-feeding, or who are of childbearing potential and not practicing a reliable method of birth control.~2. Allergy or sensitivity to any component of the test medication~3. History of poor cooperation, non-compliance with medical treatment, or unreliability.~4. Intact hymen, dyspareunia, secondary vaginismus, vulvodynia, dermatopathology of the vulva or perineum, anal fissure, associated urinary or rectal problems, complex pain disorders of the urogenital diaphragm or pelvic floor including pudendal nerve entrapment, psychiatric illness.~5. Treatment with botulinum toxin of any serotype prior to enrollment in study.~6. Any medical condition that may put the subject at increased risk with exposure to BOTOX including diagnosed myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or any other disorder that might interfere with neuromuscular function.~7. Evidence of alcohol, drug abuse or other relevant neuropsychiatric condition.~8. Infection or skin disorder at an anticipated injection site.~9. Any condition or situation that, in the investigator's opinion, may put the subject at significant risk, confound the study results, or interfere significantly with the subject's participation in the study.~10. Participation in an investigational drug study within 30 days of the Baseline Visit.

- Gender: FEMALE
- Minimum Age: 20 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- BOTOX (Type: EXPERIMENTAL): intravaginal Botox injections and progressive dilation under anesthesia to cure vaginismus.

Based on this trial design, predict the completion outcome and termination type (if applicable).